Tissuemed is pleased to announce the publication of a new clinical paper comparing the use of TissuePatchDural™ with a gel-type sealant, DuraSeal for dural closure.
The paper, is an analysis of 161 patients from the prestigious Besta Institute, Italy. All patients had undergone elective posterior fossa surgery, a neurosurgical procedure that is considered to be at a high risk of cerebrospinal fluid leakage.
The highlights of this clinical series were:
- Use of TissuePatchDural™ more than halved the number of CSF leaks
- For patients with no additional pre‑ or post‑operative risk factors, the CSF leak rate for TissuePatchDural™ was 2.1% compared to 12.5% for DuraSeal™
- There were no post-operative incisional leaks when TissuePatchDural™ was used – two were reported following use of DuralSeal™.
- Four times as many patients treated with DuralSeal™ required a secondary surgery to repair the CSF leak, compared to TissuePatchDural™.
“Effective dural sealing, particularly for posterior fossa surgery where the risk of CSF leaks is higher, is an important factor in postoperative wound management”, said David Mandley, Tissuemed’s CEO. “We’re excited to share the findings of this second comparative clinical series where the effectives sealing properties of TissuePatchDural™ have been demonstrated”
For further information relating to TissuePatchDural please click here.
For clinical data and evidence visit the publication section of the Tissuemed website.